News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,532 Results
Type
Article (294)
Company Profile (1)
Press Release (1237)
Section
Business (393)
Career Advice (11)
Deals (47)
Drug Delivery (1)
Drug Development (252)
Employer Resources (1)
FDA (28)
Job Trends (53)
News (728)
Policy (90)
Tag
Academia (19)
Allergies (1)
Alliances (77)
ALS (1)
Alzheimer's disease (7)
Antibody-drug conjugate (ADC) (2)
Approvals (20)
Artificial intelligence (1)
Autoimmune disease (2)
Bankruptcy (2)
Best Places to Work (31)
BIOSECURE Act (1)
Biotechnology (1)
Cancer (14)
Cardiovascular disease (1)
Career advice (9)
CAR-T (7)
Cell therapy (15)
Clinical research (186)
Collaboration (6)
Compensation (15)
Complete response letters (1)
COVID-19 (13)
C-suite (4)
Data (23)
Diagnostics (4)
Diversity, equity & inclusion (1)
Drug discovery (1)
Duchenne muscular dystrophy (11)
Earnings (87)
Editorial (3)
Employer resources (1)
Events (188)
Executive appointments (2)
FDA (32)
Funding (5)
Gene therapy (9)
GLP-1 (8)
Government (18)
Healthcare (31)
Immunology and inflammation (2)
Immuno-oncology (1)
Infectious disease (13)
Interviews (1)
IPO (17)
Job creations (19)
Job search strategy (6)
Layoffs (5)
Leadership (2)
Legal (18)
Lung cancer (3)
Lymphoma (4)
Manufacturing (4)
Medical device (7)
Medtech (7)
Mergers & acquisitions (30)
Metabolic disorders (2)
Neurodegenerative disease (2)
Neuropsychiatric disorders (1)
Neuroscience (13)
NextGen: Class of 2026 (15)
Non-profit (13)
Now hiring (2)
Obesity (1)
Opinion (9)
Parkinson's disease (2)
Peanut (1)
People (199)
Phase 1 (57)
Phase 2 (88)
Phase 3 (67)
Pipeline (10)
Policy (6)
Postmarket research (5)
Preclinical (41)
Press Release (1)
Radiopharmaceuticals (1)
Rare diseases (7)
Real estate (12)
Regulatory (78)
Research institute (11)
Resumes & cover letters (2)
RNA editing (1)
Series B (2)
Sickle cell disease (1)
Startups (10)
Tariffs (1)
The Weekly (1)
Vaccines (6)
Weight loss (2)
Worklife (1)
Date
Last 7 days (2)
Last 30 days (8)
Last 365 days (88)
2026 (11)
2025 (79)
2024 (89)
2023 (74)
2022 (115)
2021 (98)
2020 (63)
2019 (69)
2018 (66)
2017 (82)
2016 (84)
2015 (115)
2014 (70)
2013 (82)
2012 (75)
2011 (97)
2010 (92)
Location
Africa (6)
Asia (75)
Australia (13)
California (61)
Canada (1)
China (4)
Europe (183)
Florida (2)
Japan (2)
Maryland (1)
Massachusetts (12)
Nevada (1)
New Hampshire (1)
New Jersey (4)
New York (1)
Northern California (7)
Pennsylvania (1)
South America (8)
Southern California (52)
Texas (1)
United States (85)
Washington State (1)
1,532 Results for "fate therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2026
February 4, 2026
·
2 min read
Press Releases
Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference
November 26, 2025
·
1 min read
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - January 5, 2026
January 6, 2026
·
2 min read
Press Releases
Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
November 14, 2025
·
18 min read
Press Releases
Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer
October 15, 2025
·
7 min read
Press Releases
Fate Therapeutics to Present at Upcoming September 2025 Investor Conferences
August 25, 2025
·
1 min read
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - November 4, 2025
November 4, 2025
·
1 min read
Opinion
Fate of FDA’s Laboratory-Developed Testing Final Rule Hints at
Chevron
Overturn’s Ramifications
In one of the first demonstrations of the impact of last year’s Loper Supreme Court decision on challenges to agency authority, a judge ruled that the FDA does not have authority to regulate tests developed by clinical laboratories.
September 29, 2025
·
4 min read
·
Megan Robertson
Press Releases
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2025
October 3, 2025
·
2 min read
Press Releases
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
August 12, 2025
·
17 min read
1 of 154
Next
